首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   62524篇
  免费   4331篇
  国内免费   311篇
耳鼻咽喉   518篇
儿科学   1941篇
妇产科学   1655篇
基础医学   8919篇
口腔科学   878篇
临床医学   6320篇
内科学   13409篇
皮肤病学   1273篇
神经病学   7776篇
特种医学   1550篇
外科学   5710篇
综合类   412篇
一般理论   59篇
预防医学   6582篇
眼科学   793篇
药学   4076篇
中国医学   117篇
肿瘤学   5178篇
  2024年   87篇
  2023年   842篇
  2022年   1492篇
  2021年   2841篇
  2020年   1664篇
  2019年   2241篇
  2018年   2663篇
  2017年   1807篇
  2016年   2027篇
  2015年   2226篇
  2014年   2730篇
  2013年   3547篇
  2012年   5529篇
  2011年   5460篇
  2010年   2850篇
  2009年   2521篇
  2008年   4082篇
  2007年   3927篇
  2006年   3731篇
  2005年   3408篇
  2004年   3052篇
  2003年   2725篇
  2002年   2260篇
  2001年   276篇
  2000年   214篇
  1999年   307篇
  1998年   456篇
  1997年   334篇
  1996年   266篇
  1995年   224篇
  1994年   168篇
  1993年   150篇
  1992年   114篇
  1991年   106篇
  1990年   94篇
  1989年   83篇
  1988年   66篇
  1987年   70篇
  1986年   62篇
  1985年   51篇
  1984年   66篇
  1983年   53篇
  1982年   46篇
  1981年   49篇
  1980年   39篇
  1979年   25篇
  1978年   16篇
  1977年   26篇
  1975年   12篇
  1973年   11篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
5.
Objective: Report measured resting energy expenditure (REE) in wheelchair rugby athletes and evaluate agreement between REE and the prediction models of Chun, Cunningham, Harris-Benedict, Mifflin, Nightingale and Gorgey, and Owen.

Design: Cohort-based validation study.

Setting. Paralympic team training camp.

Participants: Fourteen internationally competitive athletes who play wheelchair rugby, 13 of whom had cervical spinal cord injuries (SCI).

Outcome Measures: A portable metabolic analyzer was used to measure REE following an overnight fast and dual-energy X-ray absorptiometry (DXA) was used to assess lean body mass for the prediction equations.

Results: REE in the current sample was 1735?±?257?kcal?×?day?1 ranging from 1324 to 2068?kcal?×?day?1 Bhambhani Y. Physiology of wheelchair racing in athletes with spinal cord injury. Sports Med 2002;32(1):2351.[Crossref], [PubMed], [Web of Science ®] [Google Scholar]. Bland–Altman analyses revealed negative mean bias but similar limits of agreement between measured REE and scores predicted by Chun, Cunningham, Mifflin, Nightingale and Gorgey, and Owen models in elite athletes who play wheelchair rugby.

Conclusion: Prediction models regressed on persons with and without SCI under-predicted REE of competitive wheelchair rugby athletes. This outcome may be explained by the higher REE/fat-free mass (FFM) ratio of current athletes compared to less active samples. Findings from the current study will help practitioners to determine nutrient intake needs on training days of varied intensity.  相似文献   
6.
7.
8.
9.
10.

Background

The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.

Methods

Adults aged ≥50 (ZOE-50) and ≥70 (ZOE-70) years were randomly vaccinated with RZV or placebo. Safety analyses were performed on the pooled total vaccinated cohort, consisting of participants receiving at least one dose of RZV or placebo. Solicited and unsolicited adverse events (AEs) were collected for 7 and 30?days after each vaccination, respectively. Serious AEs (SAEs) were collected from the first vaccination until 12?months post-last dose. Fatal AEs, vaccination-related SAEs, and potential immune-mediated diseases (pIMDs) were collected during the entire study period.

Results

Safety was evaluated in 14,645 RZV and 14,660 placebo recipients. More RZV than placebo recipients reported unsolicited AEs (50.5% versus 32.0%); the difference was driven by transient injection site and solicited systemic reactions that were generally seen in the first week post-vaccination. The occurrence of overall SAEs (RZV: 10.1%; Placebo: 10.4%), fatal AEs (RZV: 4.3%; Placebo: 4.6%), and pIMDs (RZV: 1.2%; Placebo: 1.4%) was balanced between groups. The occurrence of possible exacerbations of pIMDs was rare and similar between groups. Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.

Conclusions

No safety concerns arose, supporting the favorable benefit-risk profile of RZV.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号